An intelligent early warning system of analyzing Twitter data using machine learning on COVID-19 surveillance in the USResearch article Published on 2022-07-012022-10-05 Journal: Sensors (Basel, Switzerland) [Category] 치료기술, [키워드] BERT coronavirus disease COVID-19 COVID-19 outbreak COVID-19 surveillance detect develop Early warning system epidemic intelligence feasible Health Infectious disease intervene limitation Linear regression model media mitigate overcome pandemic public health public health authority Spread Support Surveillance Text classification WHO World Health Organization [DOI] 10.1016/j.eswa.2022.116882 [Article Type] Research article
Reliance is key to effective access and oversight of medical products in case of public health emergenciesArticle Published on 2022-07-012023-07-10 Journal: Expert review of clinical pharmacology [Category] COVID19(2023년), [키워드] COVID-19 Emergency use authorization emergency use listing international collaboration international pharmaceutical regulators programme public health emergencies Regulatory Authorities Reliance Vaccines WHO [DOI] 10.1080/17512433.2022.2088503
Circulating suPAR associates with severity and in-hospital progression of COVID-19순환하는 suPAR은 COVID-19의 중증도 및 병원 내 진행과 관련이 있습니다.Observational Study Published on 2022-07-012022-09-11 Journal: European Journal of Clinical Investigation [Category] MERS, 바이오마커, 임상, [키워드] 95% CI Accuracy Admission Adult patients age albumin assays association AUC best characterized clinical correlated COVID-19 COVID-19 disease CRP discrimination Disease progression disease severity doubling EGFR ELISA females ferritin FIVE Hospital admission hyperinflammation IMPROVE In-hospital interleukin interleukin-6 International Lactate lactate dehydrogenase LDH Linear model male marker median age observational study outcome parameter patients patients hospitalized plasma suPAR predict primary outcome measure procalcitonin progression risk stratification scale serum albumin serum lactate severity severity of COVID-19 significantly significantly lower suPAR survival survivor Treatment WHO WHO Clinical Progression Scale WHO-CPS [DOI] 10.1111/eci.13794 PMC 바로가기 [Article Type] Observational Study
The value of contact tracing and isolation in mitigation of COVID-19 epidemic: findings from outbreak investigation of COVID-19 onboard Nile Cruise Ship, Egypt, March 2020COVID-19 전염병 완화를 위한 접촉 추적 및 격리의 가치: 2020년 3월 이집트 나일 크루즈 선상에서의 COVID-19 발병 조사 결과Article Published on 2022-07-012022-09-11 Journal: BMJ Global Health [Category] COVID19(2023년), SARS, 치료기술, [키워드] age Asymptomatic Cairo case finding Case isolation category close contact Contact Contact tracing containment measures COVID-19 COVID-19 case COVID-19 patient COVID-19 patients COVID-19 transmission Cruise ship defined detect effective Egyptians Epidemiology female Health authority hotel index case index cases individual infection control investigation Isolation lab male measure Nile outbreak pandemic PCR performed positive public health questionnaire reducing secondary cases significantly higher tested triggered WHO [DOI] 10.1136/bmjgh-2022-008681 PMC 바로가기 [Article Type] Article
The 2022 outbreak and the pathobiology of the monkeypox virusArticle Published on 2022-07-012022-11-15 Journal: Journal of autoimmunity [Category] 진단, [키워드] addition African Antiviral antiviral therapies body fluids CDC center chills clade clades Congo basin Control disease effective Europe fatigue Fever headache Host hosts identity include individual Infection Infectious disease International lymph nodes mitigate Monkeypox Monkeypox outbreak 2022 muscle aches nasopharyngeal National Nigeria North America outbreak pandemic Pathogenesis Prevalence Prevent prevention raised replicate reported Respiratory droplets returned rodent shown specific treatment Spread Symptom The United States through contact Transmission transmitted Travel USA Vaccine viral pathogenesis virus virus infection virus spread Washington West while WHO World Health Organization [DOI] 10.1016/j.jaut.2022.102855 PMC 바로가기
Anti-SARS-CoV-2 IgM/IgG antibodies detection using a patch sensor containing porous microneedles and a paper-based immunoassay다공성 미세바늘을 포함하는 패치 센서와 종이 기반 면역 분석을 사용한 Anti-SARS-CoV-2 IgM/IgG 항체 검출Article Published on 2022-07-012022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 바이오마커, 유전자 메커니즘, 진단, 치료기술, [키워드] acute respiratory syndrome addition anti-SARS-CoV-2 anti-SARS-CoV-2 IgM antibodies antibody Antibody test Antibody testing antibody tests Biomarkers Blood blood sampling cause complement complementary Concentration coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 infection diagnostic tests disease effective expected global pandemic Health Organization identify IgG IgG antibodies IgG antibody IgM IgM/IgG immunoassay immunochromatographic immunochromatographic assay Immunoglobulin Immunoglobulin G immunoglobulin M in vitro infected individual infected individuals Infection Infectious disease Infectious diseases information interstitial fluid invasive limit of detection Mortality New coronavirus outbreak Pain porous Prevent Protein provided puncture site respiratory risk SARS-CoV-2 Severe Acute Respiratory Syndrome Corona Virus specific antibodies specific antibody Spread transported virus WHO widespread World Health Organization Wuhan Wuhan, China [DOI] 10.1038/s41598-022-14725-6 PMC 바로가기 [Article Type] Article
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humansResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] 임상, [키워드] Administered administration African age approach AstraZeneca AstraZeneca COVID-19 vaccine Blood ChAdOx1 nCoV-19 clinical development clinical trials conducted coronavirus disease country COVID-19 COVID-19 vaccine Denmark described Effectiveness Efficacy EMA Europe European European Medicines Agency groups Human humans immunogenicity data information initial lack limit MHRA observational study Occurrence positive Safety shown supported the vaccine thrombotic Thrombotic thrombocytopenia triggered UK Medicine union Vaccine WHO World Health Organization [DOI] 10.1016/j.therap.2022.07.003 [Article Type] Research article
Advances in the Omicron variant developmentOmicron 변종 개발의 발전Review Published on 2022-07-012022-09-11 Journal: Journal of internal medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition advance Alpha Amino acid amino acids Antiviral antiviral agent Antiviral agents antiviral drugs approved Beta booster dose booster doses Casirivimab circulating coronavirus COVID-19 Delta disease dominant dose drug effective entry of SARS-CoV-2 Epidemiology epitope Epitopes Gamma greater greater transmissibility growth advantage Health Organization humoral Imdevimab Immune escape incidence Infection inhibit Mild mild illness molecular molnupiravir monoclonal monoclonal antibodies monoclonal antibody mutations offer omicron Omicron variant pandemic Paxlovid pharmacological agent pharmacological agents Remdesivir Research respiratory SARS-CoV-2 SARS-CoV-2 virus severe acute respiratory syndrome Coronavirus Spike protein Spread the spike protein therapeutic to define Transmissibility vaccination Vaccine Vaccines variant variants Viral viral replication VoC WHO World Health Organization [DOI] 10.1111/joim.13478 PMC 바로가기 [Article Type] Review
Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2사설: Omicron 또는 B.1.1.529, SARS-CoV-2의 혈통 및 하위 혈통의 글로벌 확산에 대한 WHO(World Health Organization) 모니터링 중인 관심 혈통의 변종(VOC-LUM)Editorial Published on 2022-07-012022-09-11 Journal: Medical science monitor : international medical jo [Category] COVID19(2023년), SARS, 변종, [키워드] added B.1.1.529 concern Control dominant ECDC editorial Europe European FIVE global public health Health Organization include Infection Lineage lineages monitoring neutralization omicron Omicron variant Patient plasma prevention Prevention and control response SARS-CoV-2 SARS-CoV-2 variant shown Spread tested the WHO Transmissibility USA variant variant of SARS-CoV-2 variants variants of concern variants of interest VoC WHO World Health Organization [DOI] 10.12659/MSM.937676 PMC 바로가기 [Article Type] Editorial
Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations분자 도킹 및 분자 역학 시뮬레이션을 사용하여 SARS-CoV-2에 대한 잠재적 스파이크 억제제 식별을 위한 약물 용도 변경Article Published on 2022-07-012022-09-11 Journal: Methods (San Diego, Calif.) [Category] COVID19(2023년), SARS, 신약개발, 치료제, [키워드] ACE2 ACE2 receptor ADME administration Analysis angiotensin antiviral drugs approved drug Asthma average binding binding affinity candidate carried Compound COVID-19 COVID-19 pandemic COVID-19 treatment death develop docking drug Drug repurposing Efficacy estimates FIVE followed by free energy Hepatitis hepatitis C host cell hosts human Angiotensin-converting enzyme Human angiotensin-converting enzyme 2 identify Immunocompromised in silico Approach in vitro in vivo inhibitor Interaction leukotriene leukotriene receptor antagonist Ligand Lineage lineages membrane-bound molecular docking molecular dynamics Molecular dynamics simulation molecular dynamics simulations Multiple Multiple studies oral administration parameter plethora Protease inhibitor receptor antagonist recognize SARS-CoV-2 SARS-CoV-2 virus SARS‐CoV‐2 selected Simeprevir Spike protein Spike proteins tested the SARS-CoV-2 virus therapeutic treat Treatment variety virus WHO Zafirlukast [DOI] 10.1016/j.ymeth.2022.02.004 PMC 바로가기 [Article Type] Article